US FDA grants orphan drug status to Veloxis Pharma's Envarsus for kidney ... pharmabiz.com "FDA recognition of the potential of Envarsus as the only once-daily tacrolimus to be designated an Orphan Drug highlights these potential benefits. We continue to work on our New Drug Application (NDA), which we expect to submit by the end of 2013." Envarsus Designated Orphan Drug for Kidney Transplant Rejection Prophylaxis |
